Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

BACKGROUND: People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight, some a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Whicher, Clare Alexandra, Price, Hermione Clare, Phiri, Peter, Rathod, Shanaya, Barnard-Kelly, Katharine, Reidy, Claire, Thorne, Kerensa, Asher, Carolyn, Peveler, Robert, McCarthy, Joanne, Holt, Richard Ian Gregory
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868690/
https://ncbi.nlm.nih.gov/pubmed/31747930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3689-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky